Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024
Period Ending	Jan 14, 2026	Dec 31, 2024
Market Capitalization	1,549	679
Enterprise Value	1,050	325
Last Close Price	32.00	19.39
PB Ratio	3.20	1.78
P/TBV Ratio	3.20	1.79
Debt / Equity Ratio	0.00	0.00
Quick Ratio	16.65	28.80
Current Ratio	16.94	28.89
Return on Capital Employed (ROCE)	-25.60%	-24.90%
Earnings Yield	-5.39%	-13.46%
FCF Yield	-5.80%	-9.33%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q